Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma

Urology

Volumn 55, Issue 4, 2000, Pages 501-505

  Rioux Leclercq, Nathalie ^b   Turlin, Bruno ^a   Bansard, Jean Yves ^a   Patard, Jean Jacques ^a   Manunta, Andréa ^a   Moulinoux, Jacques Philippe ^a   Guillé, François ^a   Ramée, Marie Paule ^a   Lobel, Bernard ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; KI-67 ANTIGEN; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034114740     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00550-6     Document Type: Article

References (45)

1. Boring C.C., Squires T.S., Tong T., et al. Cancer statistics. CA Cancer J Clin. 44:1994;7-26.
2. Motzer R.J., Bander N.H., Nanus D.M. Renal cell carcinoma. N Engl J Med. 335:1996;865-875.
3. Delahunt B. Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol. 15:1998;68-76.
4. Lanigan D. Prognostic factors in renal cell carcinoma. Br J Urol. 75:1995;565-571.
5. McNichols D.W., Segura J.W., DeWeerd J.H. Renal cell carcinoma long term survival and late recurrence . J Urol. 126:1981;17-23.
6. Dorkin T.J., Robson C.N., Neal D.E. The molecular pathology of urological malignancies. J Pathol. 183:1997;380-387.
7. Fontana D., Bellina M., Gubetta L., et al. Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol. 148:1992;1149-1151.
8. Cip1/WAF/Sdi1 . J Pathol. 183:1997;134-140.
9. Reiter R.E., Anglard P., Liu S., et al. Chromosome 17p deletions in renal cell carcinoma. Cancer Res. 53:1993;3092-3097.
10. Nakopoulou L., Vourlakou C., Zervas A., et al. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathological correlates. Hum Pathol. 29:1998;146-154.
11. Oomens E.H.G.M., Van Steenbrugge G.J., Van Der Kwaxt T.H., et al. Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the proliferative cell fraction of human prostatic carcinoma. J Urol. 145:1991;81-85.
12. Gerdes J., Lemke H., Baisch H., et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 13:1984;1710-1715.
13. Key G., Peterson J.L., Becker M.H.G., et al. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol. 46:1993;1080-1084.
14. Munakata S., Hendricks J. Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem. 41:1993;1241-1246.
15. Fuhrman S., Lasky L., Lumas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 6:1982;655-663.
16. Sobin LH, and Wittekind CH, for the International Union Against Cancer (IUCC): TNM Classification of Malignant Tumors, 5th ed. New York, Wiley-Liss, 1997, pp 180-182.
17. Baas I.O., Mulder J.-W.R., Offerhaus G.L.A., et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol. 172:1994;5-12.
18. Cattoretti G., Pileri S., Parravicini C., et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol. 17:1993;83-98.
19. Delahunt B., Bethwaite P.B., Thornton A., et al. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Cancer. 75:1995;2714-2719.
20. Kaplan M., Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc. 53:1958;457-481.
21. Cox D.R. Regression models and life tables. J R Stat Soc. 34:(B):1972;187-202.
22. Brambilla E., Negoescu A., Gazzeri A., et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol. 149:1996;1941-1952.
23. Gerdes J., Schwab U., Lemke H., et al. Production of a mouse monoclonal antibody with a human antigen associated with cell proliferation. Int J Cancer. 31:1983;13-18.
24. Aaltomaa S., Lipponen P., Ala-Opas M., et al. Prognostic value of Ki-67 expression in renal cell carcinomas. Eur Urol. 31:1997;350-355.
25. de Riese W.T.W., Crabtree W.N., Allhoff E.P., et al. Prognostic significance of Ki-67 immunostaining in non-metastatic renal cell carcinoma. J Clin Oncol. 11:1993;1804-1808.
26. Hindermann W., Berndt A., Wunderlich H., et al. Quantitative evaluation of apoptosis and proliferation in renal cell carcinoma. Correlation to tumor subtype, cytological grade according to Thoenes-classification and the occurrence of metastasis. Pathol Res Pract. 193:1997;1-7.
27. Tannapfel A., Hahn H.A., Katalinic A., et al. Incidence of apoptosis, cell proliferation and p53 expression in renal cell carcinoma. Anticancer Res. 17:1997;1155-1162.
28. Tannapfel A., Hahn H.A., Katalinic A., et al. Prognostic significance of cellular proliferation markers in renal cell carcinoma. Cancer. 77:1996;164-171.
29. Jochum W., Schroder S., Al-Taha R., et al. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinoma. Cancer. 77:1996;514-521.
30. Hofmockel G., Tsatalpas P., Müller H., et al. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer. 76:1995;296-306.
31. Barnes D.M., Dublin E.A., Fisher C.J., et al. Immunohistochemical detection of p53 in mammary carcinoma an important new independent indicator of prognosis? Hum Pathol. 24:1993;469-476.
32. Sinik Z., Alkibay T., Ataoglu O., et al. Nuclear p53 overexpression in bladder, prostate, and renal carcinomas. Int J Urol. 4:1997;546-551.
33. Tenaud C., Negoescu A., Labat-Moleur F., et al. p53 immunolabeling in archival paraffin-embedded tissues optimal protocol based on microwave heating for eight antibodies on lung carcinomas . Mod Pathol. 7:1994;853-859.
34. Zhang X.H., Takenaka I., Sato C., et al. p53 and HER-2 alterations in renal cell carcinoma. Urology. 50:1997;636-642.
35. Bot F.J., Godschalk J.C.J., Krishnadath K.K., et al. Prognostic factors in renal cell carcinoma immunohistochemical detection of p53 protein versus clinico-pathological parameters . Int J Cancer. 57:1994;634-637.
36. Hofmockel G., Wittmann A., Dammrich J., et al. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas no evidence for prognostic significance . Anticancer Res. 16:1996;3807-3811.
37. Walsh C.J., Kay E.W., Lynch T., et al. Evaluation of p53 protein expression in renal cell carcinoma comparison of two antibodies . Br J Biomed Sci. 53:1996;179-181.
38. Lai R., El Dabbagh L., Mourad W.A. Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma evidence of a precursor lesion . Mod Pathol. 9:1996;690-695.
39. Herbst C., Kosmehl H., Stiller K.J., et al. Evaluation of microvessel density by computerised image analysis in human renal cell carcinoma. Correlation to pT category, nuclear grade, proliferative activity and occurrence of metastasis. J Cancer Res Clin Oncol. 124:1998;141-147.
40. Masuda H., Kurita Y., Suzuki A., et al. Prognostic factors for renal cell carcinoma a multivariate analysis of 320 cases . Int J Urol. 4:1997;247-253.
41. Nativ O., Sabo E., Raviv G., et al. The impact of tumor size on clinical outcome in patients with localized renal cell carcinoma treated by radical nephrectomy. J Urol. 158:1997;729-732.
42. Sabo E., Miselevich I., Bejar J., et al. The role of vimentin expression in predicting the long-term outcome of patients with localized renal cell carcinoma. Br J Urol. 80:1997;864-868.
43. Vasavada S.P., Novick A.C., Williams B.R. p53, bcl-2 and bax expression in renal cell carcinoma. Urology. 51:1998;1057-1061.
44. Yasunaga Y., Shin M., Miki T., et al. Prognostic factors of renal cell carcinoma a multivariate analysis . J Surg Oncol. 68:1998;11-18.
45. Papadopoulos I., Weichert-Jacobsen K., Wacker H.H., et al. Correlation between DNA ploidy, proliferation marker Ki-67 and early tumor progression in renal cell carcinoma. A prospective study. Eur Urol. 31:1997;49-53.